Non-coding CGG repeat expansions within the 5' untranslated region are implicated in a range of neurological disorders, including fragile X-associated tremor/ataxia syndrome, oculopharyngeal myopathy with leukodystrophy, and oculopharyngodistal myopathy. This review outlined the general characteristics of diseases associated with non-coding CGG repeat expansions, detailing their clinical manifestations and neuroimaging patterns, which often overlap and indicate shared pathophysiological traits. We summarized the underlying molecular mechanisms of these disorders, providing new insights into the roles that DNA, RNA, and toxic proteins play. Understanding these mechanisms is crucial for the development of targeted therapeutic strategies. These strategies include a range of approaches, such as antisense oligonucleotides, RNA interference, genomic DNA editing, small molecule interventions, and other treatments aimed at correcting the dysregulated processes inherent in these disorders. A deeper understanding of the shared mechanisms among non-coding CGG repeat expansion disorders may hold the potential to catalyze the development of innovative therapies, ultimately offering relief to individuals grappling with these debilitating neurological conditions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s12035-024-04239-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ascorbic Acid Ameliorates Molecular and Developmental Defects in Human-Induced Pluripotent Stem Cell and Cerebral Organoid Models of Fragile X Syndrome.
Int J Mol Sci
November 2024
Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland.
Fragile X Syndrome (FX) is the most common form of inherited cognitive impairment and falls under the broader category of Autism Spectrum Disorders (ASD). FX is caused by a CGG trinucleotide repeat expansion in the non-coding region of the X-linked () gene, leading to its hypermethylation and epigenetic silencing. Animal models of FX rely on the deletion of the gene, which fails to replicate the epigenetic silencing mechanism of the gene observed in human patients.
View Article and Find Full Text PDFEpigenetic insights into Fragile X Syndrome.
Front Cell Dev Biol
August 2024
The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Article Synopsis
- Fragile X Syndrome (FXS) is a genetic neurodevelopmental disorder linked to intellectual disabilities and autism, caused by an abnormal expansion of the CGG repeat in the FMR1 gene.
- Over 200 repeats silence the FMR1 gene, resulting in the absence of the Fragile X mental retardation protein (FMRP), which is crucial for normal brain development.
- Recent research highlights the importance of epigenetics in FXS, focusing on how gene expression can be modulated without altering DNA sequences, offering new potential avenues for treatment.
Article Synopsis
- Oculopharyngodistal myopathy (OPDM) is a genetic muscle disease that causes drooping eyelids, trouble swallowing, and weakness in the arms and legs.
- Recent research found repeating sequences in a gene called ABCD3 in people with OPDM from European backgrounds, while similar repeats were only discovered in certain Asian groups before.
- These long repeats in the ABCD3 gene might play a role in the muscle problems seen in OPDM, suggesting a link between these repeats and the weakness that affects patients.
Linking LRP12 CGG repeat expansion to inherited peripheral neuropathy.
J Neurol Neurosurg Psychiatry
January 2025
Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Article Synopsis
- * Researchers screened 1555 Japanese IPN patients for CGG repeat expansions using advanced techniques, finding 44 cases with this genetic marker, making it a common cause of the condition.
- * The findings underscore the importance of tailored screening strategies in clinical settings, particularly for identifying Charcot-Marie-Tooth disease (CMT) cases linked to CGG repeat expansions.
Advances on the Mechanisms and Therapeutic Strategies in Non-coding CGG Repeat Expansion Diseases.
Mol Neurobiol
December 2024
Departments of Neurology, The First Affiliated Hospital of Soochow University, Suzhou City, China.
Non-coding CGG repeat expansions within the 5' untranslated region are implicated in a range of neurological disorders, including fragile X-associated tremor/ataxia syndrome, oculopharyngeal myopathy with leukodystrophy, and oculopharyngodistal myopathy. This review outlined the general characteristics of diseases associated with non-coding CGG repeat expansions, detailing their clinical manifestations and neuroimaging patterns, which often overlap and indicate shared pathophysiological traits. We summarized the underlying molecular mechanisms of these disorders, providing new insights into the roles that DNA, RNA, and toxic proteins play.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!